News & Media
About Abiomed and Impella® Heart Pumps
Based in Danvers, Massachusetts, USA, Abiomed, Inc., part of Johnson & Johnson MedTech, is a leading provider of medical technology that provides circulatory support and oxygenation. Our products are designed to enable the heart to rest and recover by improving blood flow.
Impella heart pumps are the only U.S. Food and Drug Administration-approved percutaneous heart pump technology indicated for patients with severe coronary artery disease requiring high-risk PCI or treatment of AMI cardiogenic shock. Impella has the unique ability to enable your heart to recover, allowing patients to return home from the hospital with their native hearts.
Featured News
Media Center for Journalists
Abiomed’s media kit provides a comprehensive source of information for you to tell your story, from product images to b-roll video.
Explore the unique stories of people with complex heart disease and advanced heart failure who were able to recover their own hearts.
Contact Us
Christian Pott
Assoc. Director Corporate Communications, Public Affairs and Sustainability
ABIOMED Europe GmbH
Neuenhofer Weg 3 | 52074 Aachen
E-Mail: cpott(at)abiomed.com
Phone: +49 241 8860 177
NPS-2567